IGF1 and cancer: Further supporting the complexity of crosstalk between IGF-1R and other tyrosine kinase receptor pathways, unclear synergistic actions of EGF, PDGF, TGF-β, and IGF induce stemness, cancer progression and metastasis, drug resistance, and tumor relapse in various cancer types (33, 39, 53, 77).